Stockscreener 앱 받기
26.27
0.19%
-0.05
시간 외 거래:
26.27
전일 마감가:
$26.32
열려 있는:
$26.06
하루 거래량:
525.52K
Relative Volume:
0.53
시가총액:
$1.51B
수익:
$2.25B
순이익/손실:
$-1.18B
주가수익비율:
-1.2695
EPS:
-20.6926
순현금흐름:
$19.92M
1주 성능:
+5.67%
1개월 성능:
+20.23%
6개월 성능:
-18.94%
1년 성능:
-17.80%
1일 변동 폭
$25.98
$26.79
1주일 범위
$24.87
$27.04
52주 변동 폭
$21.00
$37.85
Enovis Corp Stock (ENOV) Company Profile
명칭
Enovis Corp
전화
(302) 252-9160
주소
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
26.27 | 1.51B | 2.25B | -1.18B | 19.92M | -20.69 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-17 | 재개 | William Blair | Outperform |
| 2026-01-06 | 개시 | BTIG Research | Buy |
| 2024-10-03 | 개시 | JMP Securities | Mkt Outperform |
| 2024-06-13 | 개시 | JP Morgan | Neutral |
| 2024-02-13 | 개시 | Stephens | Overweight |
| 2024-01-22 | 개시 | UBS | Buy |
| 2024-01-03 | 개시 | William Blair | Outperform |
| 2023-12-15 | 재확인 | Needham | Buy |
| 2023-10-20 | 개시 | ROTH MKM | Buy |
| 2023-06-26 | 개시 | Needham | Buy |
| 2023-05-12 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-10-11 | 개시 | Goldman | Buy |
| 2022-09-12 | 개시 | Canaccord Genuity | Buy |
| 2022-09-12 | 개시 | Evercore ISI | Outperform |
| 2022-06-28 | 개시 | Argus | Hold |
| 2022-06-27 | 재개 | Loop Capital | Buy |
| 2022-06-16 | 개시 | Wells Fargo | Equal Weight |
모두보기
Enovis Corp 주식(ENOV)의 최신 뉴스
Analyst backs Enovis on cash flow turnaround - MSN
Does The Recent Rebound In Enovis (ENOV) Share Price Reflect Its True Worth? - Yahoo Finance
ENOV Assumed by William Blair -- Rating Maintained as Outperform - GuruFocus
Analyst Backs Enovis On Cash Flow Turnaround - Benzinga
Enovis Coverage Assumed by William Blair at Outperform - Moomoo
Enovis' (ENOV) "Outperform" Rating Reaffirmed at William Blair - MarketBeat
William Blair assumes Enovis stock coverage with outperform rating By Investing.com - Investing.com Australia
William Blair assumes Enovis stock coverage with outperform rating - Investing.com
Enovis assumed with an Outperform at William Blair - TipRanks
Enovis: Discounted Valuation With Clear Free Cash Flow Upside and Product Catalysts Support Buy Rating - TipRanks
Enovis Corporation (NYSE:ENOV) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Is It Time To Reconsider Enovis (ENOV) After Recent Share Price Rebound - simplywall.st
Enovis : Proxy Statement 2026 - marketscreener.com
Enovis price target lowered to $39 from $43 at BTIG - TipRanks
BTIG Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $39 - 富途牛牛
Enovis to Host First Quarter 2026 Results Conference Call on May 7th - marketscreener.com
A Look At Enovis (ENOV) Valuation After Recent Share Price Rebound From A Weaker Year - simplywall.st
Enovis (NYSE: ENOV) HR chief reports 15,552 shares and stock options - Stock Titan
Enovis to Host Q1 2026 Results Call on May 7th - National Today
Enovis will release first-quarter results before a May 7 webcast - Stock Titan
ENOV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Enovis (NYSE: ENOV) sets 2026 virtual meeting, pay and plan votes - Stock Titan
Evercore Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $35 - 富途牛牛
Enovis price target lowered to $35 from $36 at Evercore ISI - TipRanks
Enovis Corporation $ENOV Shares Bought by Allspring Global Investments Holdings LLC - MarketBeat
Enovis and Schrodinger Stocks Compared - National Today
Enovis at 2026 CG Musculoskeletal Conference: Strategic Growth and Innovation - Investing.com
Enovis Corporation (ENOV) stock price, news, quote and history - Yahoo Finance Singapore
Director at Enovis (NYSE: ENOV) receives 770-share stock grant - Stock Titan
Enovis Corp (C520.MU) stock price, news, quote and history - Yahoo Finance Singapore
Neeraj Chandola joins Enovis India as HeadHR - ETHRWorld.com
Neeraj Chandola to head human resources for India, at Enovis - HR Katha
Trading Recap: Is Enovis Corporation undervalued by DCF analysis2026 Macro Impact & AI Powered Market Entry Strategies - baoquankhu1.vn
Enovis Sells Dr. Comfort Business to Promus Equity Partners for Up to $60 Million - MSN
Enovis Corporation (ENOV) Stock Forecasts - Yahoo Finance
Enovis Corporation (ENOV) Stock Price Quote Today & Current Price Chart - capital.com
Breakout Zone: What is Enovis Corporations 5 year growth outlookMarket Sentiment Review & Consistent Profit Trade Alerts - baoquankhu1.vn
Trading Recap: What is Enovis Corporations 5 year growth outlookMarket Trend Report & Risk Controlled Daily Plans - baoquankhu1.vn
Enovis (NYSE:ENOV) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health stocks trade down, what you need to know - MSN
Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health Stocks Trade Down, What You Need To Know - Yahoo Finance
Press Release: Enovis Announces First Quarter 2025 Results - 富途牛牛
[SCHEDULE 13G/A] Enovis CORP Amended Passive Investment Disclosure - Stock Titan
Wall Street analysts see a 100.71% upside in Enovis (ENOV): Can the stock really move this high? - MSN
Enovis Delivers 7% Sales Growth in Q2, Raises Full-Year Outlook - MSN
DAVENPORT & Co LLC Cuts Stock Holdings in Enovis Corporation $ENOV - MarketBeat
Enovis Corporation (NYSE:ENOV) Q4 2025 earnings call transcript - MSN
Wall Street experts predict Enovis (ENOV) could climb by 100.71%: Is such a surge truly possible for the stock? - bitget.com
Wall Street Analysts See a 100.71% Upside in Enovis (ENOV): Can the Stock Really Move This High? - Zacks Investment Research
Enovis Corp (ENOV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.74%
1.72%
자본화:
|
볼륨(24시간):